title: The Combination of 80 Years of Age and Metastatic Castration-Resistant Prostate Cancer Remain an Uphill Battle: A Case Report with Cabazitaxel as a Double-Edged Sword.
abstract: We report the case of an 80-year-old patient who presented with a progressive prostate metastatic cancer with poor performance status. The patient had already benefitted from docetaxel and abiraterone. A new line of chemotherapy by cabazitaxel was started with good response, and there was a dramatic improvement in general status and pain symptoms. Age and performance status alone should not be limiting decision factors for elderly cancer patients.
authors.affiliation: Medical Oncology, Lucien Neuwirth Cancer Institute, Saint Priest en Jarez, France.
authors.forename: Benoite
authors.initials: B
authors.lastname: Méry
authors.forename: Jane-Chloé
authors.initials: JC
authors.lastname: Trone
authors.forename: Guillaume
authors.initials: G
authors.lastname: Moriceau
authors.forename: Alexander Tuan
authors.initials: AT
authors.lastname: Falk
authors.forename: Aline
authors.initials: A
authors.lastname: Guillot
authors.forename: Cécile
authors.initials: C
authors.lastname: Pacaut
authors.forename: Olivier
authors.initials: O
authors.lastname: Collard
authors.forename: Nicolas
authors.initials: N
authors.lastname: Magné
mesh_terms: D000367:Age Factors; D000369:Aged, 80 and over; D006801:Humans; D008297:Male; D064129:Prostatic Neoplasms, Castration-Resistant / Q000175:diagnosis* / Q000188:drug therapy*; D043823:Taxoids / Q000627:therapeutic use*
chemical_list: D043823:Taxoids; C552428:cabazitaxel